头颈癌住院患者静脉血栓栓塞症:局限、区域与转移性病变的差异
基于2016—2020年美国全国住院患者样本,纳入62 032例(加权310 160例)成人头颈癌住院患者,排除其他原发恶性肿瘤。转移性头颈癌(而非区域性疾病)与更高的静脉血栓栓塞症(VTE)、肺栓塞(PE)和深静脉血栓(DVT)风险相关,且VTE与住院死亡率和延长住院时间相关。
要点
- 转移性头颈癌住院患者VTE风险高于局限性患者(aOR 1.52)。
- 区域性与局限性头颈癌的VTE风险无显著差异。
- 合并VTE的头颈癌住院患者死亡风险和住院时间显著增加。
核心结论
- 在住院头颈癌患者中,远处转移(而非区域转移)与更高的VTE风险相关,VTE与不良住院结局相关。
研究设计与样本
- 回顾性队列研究,使用2016—2020年美国全国住院患者样本(NIS)数据库,纳入≥18岁头颈癌成人住院患者,排除其他原发恶性肿瘤,按局限性、区域性和转移性分层。
主要发现
- 在62 032例非加权(加权310 160例)住院记录中,局限性头颈癌占75.0%,区域性占12.7%,转移性占12.3%。
- 总VTE发生率为2.6%(局限性2.4%、区域性2.3%、转移性4.1%)。
- 与局限性头颈癌相比,区域性头颈癌与VTE、PE或DVT风险增加无关。
- 转移性头颈癌与更高的VTE(aOR 1.52;95% CI:1.30-1.78)、PE(aOR 1.61;95% CI:1.32-1.98)和DVT(aOR 1.47;95% CI:1.18-1.83)风险相关。
- VTE与住院死亡率增加(aOR 1.98;95% CI:1.64-2.40)和延长住院时间(LOS ≥ 7天;aOR 2.14;95% CI:1.92-2.39)相关。
临床怎么用
- 对转移性头颈癌住院患者应提高VTE风险意识,考虑个体化血栓预防与监测。
- 合并VTE的头颈癌住院患者需关注住院死亡和延长住院时间风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Venous thromboembolism (VTE) is a known complication in cancer patients, but data in head and neck cancer (HNC)-particularly distinguishing localized, regional, and metastatic disease-are limited. METHODS: Using the 2016-2020 National Inpatient Sample, we examined adults ≥ 18 years with HNC, excluding patients with another primary malignancy. Metastatic status was categorized as localized, regional, and metastatic. Outcomes included odds of VTE, pulmonary embolism (PE), deep vein thrombosis (DVT), inhospital mortality, and prolonged length of stay (LOS ≥ 7 days). Multivariable logistic regression identified factors associated with these outcomes. RESULTS: Among 62 032 unweighted (310 160 weighted) admissions, 75.0% had localized HNC, 12.7% had regional HNC, and 12.3% had metastatic HNC; 2.6% had VTE (2.4% localized HNC, 2.3% regional HNC, and 4.1% metastatic HNC). Compared with localized HNC, regional HNC was not associated with increased odds of VTE, PE, or DVT, whereas metastatic HNC was associated with higher adjusted odds of VTE (aOR 1.52; 95% CI: 1.30-1.78), PE (aOR 1.61; 95% CI: 1.32-1.98), and DVT (aOR 1.47; 95% CI: 1.18-1.83). VTE was associated with increased inhospital mortality (aOR 1.98; 95% CI: 1.64-2.40) and prolonged LOS (aOR 2.14; 95% CI: 1.92-2.39). CONCLUSION: In hospitalized patients, distant, but not regional, metastatic HNC is associated with higher odds of VTE, and VTE is associated with adverse in-hospital outcomes including increased mortality and prolonged LOS.
引用
- LoPolito AG, Akhiwu T, Gao MZ, et al. Venous Thromboembolism in Patients Hospitalized With Localized, Regional, and Metastatic Head and Neck Cancer. Head Neck. 2026. PMID: 42902813. doi:10.1002/hed.70522
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。